On Wednesday, January 17, 2024, a distribution of $32 million was made to federally-recognized Native American Tribes as part of the McKinsey Opioid Epidemic Tribal Settlement. Lieff Cabraser serves as Plaintiffs’ lead counsel in the McKinsey & Co. National Prescription Opiate Litigation, and has been at the forefront of this crucial legal battle, striving to
Dedicated $39.5 million portion of proposed national $269.5 million McKinsey opioids settlement will go to Native American Tribes Global management and consulting company McKinsey & Co. describes itself as “the trusted advisor to the world’s leading businesses, governments, and institutions.” The company was sued in the wake of the national opioids harm litigation for its
Litigation to date has recovered more than $50 billion for communities nationwide to address and abate opioid epidemic June 8, 2023 – An additional $18.75 billion will now be provided to communities nationwide to directly address the opioid epidemic, as a vast majority of state and local governments confirmed participation in global settlements that resolve
As reported by Law360, a pivotal legal victory has been achieved in the fight against the U.S. opioid crisis, with Walgreens agreeing to a $230 million payment to the city of San Francisco. The payment is the culmination of an intense bench trial which established Walgreens’ culpability for its part in the city’s opioid epidemic.
The California Daily Journal’s 2023 CLAY award recognizes Lieff Cabraser, Robbins Geller, and the San Francisco City Attorney’s Office for their collective efforts in winning a landmark opioids bench trial against Walgreens pharmacy for substantially contributing to the opioid epidemic in San Francisco We are proud to announce that the California Daily Journal/California Lawyer has
The Recorder has published an in-depth piece on Lieff Cabraser partner Richard M. Heiman highlighting his recent hard-fought work successfully representing the City of San Francisco in a landmark opioid bench trial against Walgreens pharmacy for its role in the City’s current drug crisis. In August 2022, the Court in the bench trial found Walgreens liable for
Federal judge finds Walgreens liable for substantially contributing to the opioid crisis in San Francisco SAN FRANCISCO (August 10, 2022) — San Francisco City Attorney David Chiu announced today that San Francisco acting on behalf of the People of the State of California won its landmark opioid trial against Walgreens pharmacy. Judge Charles R. Breyer
As reported by The New York Times (subscription) and multiple other outlets, Native American tribes have reached a $590 million proposed settlement agreement with Johnson & Johnson and three of the country’s largest opioid distributors to resolve claims over the companies’ alleged role in fueling the massive opioid addiction crisis responsible for ravaging hundreds of
As reported by Law360, in a first-of-its-kind ruling, a federal jury has found pharmacy giants CVS, Walgreens and Walmart liable for fueling the opioid addiction crisis in two Ohio counties. After a six-week trial and one week of deliberations, jurors concluded that the sale and distribution of huge amounts of prescription opioids by the pharmacy
Lieff Cabraser partner Mark P. Chalos spoke as a featured panelist at the Georgetown Law School virtual summit “Opioid Litigation Summit: Maximizing the Impact of Settlements to Address the Opioid Epidemic.” Mark participated in “State of the Settlements, Bellwethers, and Settlement Design Innovations.”